Post-ischaemic activation of kinases in the pre-conditioning-like cardioprotective effect of the platelet-activating factor

Acta Physiologica

Volumn 197, Issue 3, 2009, Pages 175-185

  Penna, C ^a,b   Mognetti, B ^a   Tullio, F ^a,c   Gattullo, D ^a   Mancardi, D ^a   Moro, F ^a   Pagliaro, P ^a,b   Alloatti, G ^b,c  

^a UNIVERSITY OF TURIN   (Italy)

^b National Institute for Cardiovascular Research   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

Infarct size; Phosphoinositide 3 kinase; Protein kinase C; Reperfusion injury

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ATRACTYLOSIDE; CHELERYTHRINE; GLYCOGEN SYNTHASE KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE C EPSILON; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; EXERCISE RECOVERY; HEART CONTRACTION; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE ISCHEMIA; HEART PERFUSION; HEART PROTECTION; HEART VENTRICLE FUNCTION; ISOLATED HEART; MALE; MITOCHONDRIAL PERMEABILITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; REPERFUSION;

ANIMALS; BLOTTING, WESTERN; ENZYME ACTIVATION; GLYCOGEN SYNTHASE KINASE 3; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; ORGAN CULTURE TECHNIQUES; PLATELET ACTIVATING FACTOR; PROTEIN KINASES; RATS; RATS, WISTAR;

EID: 70350490313     PISSN: 17481708     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1748-1716.2009.02000.x     Document Type: Article

References (37)

1. Cavallo-Perin, P., Lupia, E., Gruden, G., Olivetti, C., De Martino, A., Cassader, M., Furlani, D., Servillo, L., Quagliuolo, L., Iorio, E., Boccellino, M.R., Montrucchio, G. Camussi, G. 2000. Increased blood levels of platelet activating factor in insulin-dependent diabetic patients with microalbuminuria. Nephrol Dial Transplant 15, 994 999.
2. Cohen, M.V., Yang, X.M. Downey, J.M. 2006. Nitric oxide is a preconditioning mimetic and cardioprotectant and is the basis of many available infarct-sparing strategies. Cardiovasc Res 70, 231 239.
3. Gelpi, R.J., Morales, C., Cohen, M.V. Downey, J.M. 2002. Xanthine oxidase contributes to preconditioning's preservation of left ventricular developed pressure in isolated rat heart: developed pressure may not be an appropriate end-point for studies of preconditioning. Basic Res Cardiol 97, 40 46.
4. Griffiths, E.J. Halestrap, A.P. 1995. Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion. Biochem J 307, 93 98.
5. Gustafsson, A.B. Gottlieb, R.A. 2008. Heart mitochondria: gates of life and death. Cardiovasc Res 77, 334 343.
6. Halestrap, A.P., Clarke, S.J. Khaliulin, I. 2007. The role of mitochondria in protection of the heart by preconditioning. Biochim Biophys Acta 1767, 1007 1031.
7. Hausenloy, D.J. Yellon, D.M. 2006a. Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection. Heart Fail Rev 12, 217 234.
8. Hausenloy, D.J. Yellon, D.M. 2006b. Survival kinases in ischemic preconditioning and postconditioning. Cardiovasc Res 70, 240 253.
9. Hausenloy, D.J. Yellon, D.M. 2007. Preconditioning and postconditioning: united at reperfusion. Pharmacol Ther 116, 173 191.
10. Hausenloy, D.J., Maddock, H.L., Baxter, G.F. Yellon, D.M. 2002. Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? Cardiovasc Res 55, 534 543.
11. Janero, D.R. Burghardt, C. 1990. Production and release of platelet activating factor by the injured heart-muscle cell (cardiomyocyte). Res Commun Chem Pathol Pharmacol 67, 201 218.
12. Juhaszova, M., Zorov, D.B., Kim, S.H., Pepe, S., Fu, Q., Fishbein, K.W., Ziman, B.D., Wang, S., Ytrehus, K., Antos, C.L., Olson, E.N. Sollott, S.J. 2004. Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest 113, 1535 1549.
13. Khaliulin, I., Clarke, S.J., Lin, H., Parker, J., Suleiman, M.S. Halestrap, A.P. 2007. Temperature preconditioning of isolated rat hearts - a potent cardioprotective mechanism involving a reduction in oxidative stress and inhibition of the mitochondrial permeability transition pore. J Physiol 581, 1147 1161.
14. Kimura, Y., Iyengar, J., Subramanian, R., Cordis, G.A. Das, D.K. 1992. Preconditioning of the heart by repeated stunning: attenuation of post-ischemic dysfunction. Basic Res Cardiol 87, 128 138.
15. Leary, P.J., Rajasekaran, S., Morrison, R.R., Tuomanen, E.I., Chin, T.K. Hofmann, P.A. 2008. A cardioprotective role for platelet activating factor through NOS dependent S-nitrosylation. Am J Physiol Heart Circ Physiol 294, H2775 H2784.
16. Liu, Y. Downey, J.M. 1992. Ischemic preconditioning protects against infarction in rat heart. Am J Physiol 263, H1107 H1112.
17. Ludbrook, J. 1994. Repeated measurements and multiple comparison in cardiovascular research. Cardiovasc Res 28, 301 311.
18. Ma, X.L., Gao, F., Liu, G.L., Lopez, B.L., Christopher, T.A., Fukuto, J.M., Wink, D.A. Feelisch, M. 1999. Opposite effects of nitric oxide and nitroxyl on postischemic myocardial injury. Proc Natl Acad Sci USA 96, 14617 14622.
19. Maggirwar, S.B., Tong, N., Ramirez, S., Gelbard, H.A. Dewhurst, S. 1999. HIV-1 Tat-mediated activation of glycogen synthase kinase-3beta contributes to Tat-mediated neurotoxicity. J Neurochem 73, 578 586.
20. Montrucchio, G., Alloatti, G. Camussi, G. 2000. Role of platelet-activating factor in cardiovascular pathophysiology. Physiol Rev 80, 1669 1699.
21. Murphy, E. 2004a. Inhibit GSK-3beta or there's heartbreak dead ahead. J Clin Invest 113, 1526 1528.
22. Murphy, E. 2004b. Primary and secondary signaling pathways in early preconditioning that converge on the mitochondria to produce cardioprotection. Circ Res 94, 7 16.
23. Murphy, E. Steenbergen, C. 2005. Inhibition of GSK-3beta as a target for cardioprotection: the importance of timing, location, duration and degree of inhibition. Expert Opin Ther Targets 9, 447 456.
24. Murry, C.E., Jennings, R.B. Reimer, K.A. 1986. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74, 1124 1136.
25. Pagliaro, P., Gattullo, D., Rastaldo, R. Losano, G. 2001. Ischemic preconditioning: from the first to the second window of protection. Life Sci 69, 1 15.
26. Pagliaro, P., Mancardi, D., Rastaldo, R., Penna, C., Gattullo, D., Miranda, K.M., Feelisch, M., Wink, D.A., Kass, D.A. Paolocci, N. 2003. Nitroxyl affords thiol-sensitive myocardial protective effects akin to early preconditioning. Free Radic Biol Med 34, 33 43.
27. Park, S.S., Zhao, H., Mueller, R.A. Xu, Z. 2006. Bradykinin prevents reperfusion injury by targeting mitochondrial permeability transition pore through glycogen synthase kinase 3beta. J Mol Cell Cardiol 40, 708 716.
28. Penna, C., Alloatti, G., Cappello, S., Gattullo, D., Berta, G., Mognetti, B., Losano, G. Pagliaro, P. 2005. Platelet-activating factor induces cardioprotection in isolated rat heart akin to ischemic preconditioning: role of phosphoinositide 3-kinase and protein kinase C activation. Am J Physiol Heart Circ Physiol 288, H2512 H2520.
29. Penna, C., Rastaldo, R., Mancardi, D., Raimondo, S., Cappello, S., Gattullo, D., Losano, G. Pagliaro, P. 2006. Post-conditioning induced cardioprotection requires signaling through a redox-sensitive mechanism, mitochondrial ATP-sensitive K+ channel and protein kinase C activation. Basic Res Cardiol 101, 180 189.
30. Penna, C., Mognetti, B., Tullio, F., Gattullo, D., Mancardi, D., Pagliaro, P. Alloatti, G. 2008a. The platelet activating factor triggers preconditioning-like cardioprotective effect via mitochondrial K-ATP channels and redox-sensible signaling. J Physiol Pharmacol 59, 47 54.
31. Penna, C., Tullio, F., Merlino, A., Moro, F., Raimondo, S., Rastaldo, R., Perrelli, M.G., Mancardi, D. Pagliaro, P. 2008b. Postconditioning cardioprotection against infarct size and post-ischemic systolic dysfunction is influenced by gender. Basic Res Cardiol In press [Epub ahead of print].
32. Skyschally, A., Schulz, R. Heusch, G. 2008. Pathophysiology of myocardial infarction: protection by ischemic pre- and postconditioning. Herz 33, 88 100.
33. Smith, R.M., Lecour, S. Sack, M.N. 2002. Innate immunity and cardiac preconditioning: a putative intrinsic cardioprotective program. Cardiovasc Res 55, 474 482.
34. Stafforini, D.M., McIntyre, T.M., Zimmerman, G.A. Prescott, S.M. 2003. Platelet-activating factor, a pleiotrophic mediator of physiological and pathological processes. Crit Rev Clin Lab Sci 40, 643 672.
35. Stangl, V., Baumann, G., Stangl, K. Felix, S.B. 2002. Negative inotropic mediators released from the heart after myocardial ischaemia-reperfusion. Cardiovasc Res 53, 12 30.
36. Tong, N., Sanchez, J.F., Maggirwar, S.B., Ramirez, S.H., Guo, H., Dewhurst, S. Gelbard, H.A. 2001. Activation of glycogen synthase kinase 3 beta (GSK-3beta) by platelet activating factor mediates migration and cell death in cerebellar granule neurons. Eur J Neurosci 13, 1913 1922.
37. Yellon, D.M. Downey, J.M. 2003. Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev 83, 1113 1151.